Targeting Polyphosphate Kinases in the Fight against Pseudomonas aeruginosa
Polyphosphate (polyP) is a universally conserved molecule that plays critical roles in managing bacterial stress responses, in addition to biofilm formation and virulence. The enzymes that make polyphosphate molecules are called polyphosphate kinases (PPKs). Since these enzymes are not conserved in...
Saved in:
Published in | mBio Vol. 12; no. 4; p. e0147721 |
---|---|
Main Authors | , |
Format | Journal Article |
Language | English |
Published |
United States
American Society for Microbiology
31.08.2021
|
Subjects | |
Online Access | Get full text |
Cover
Loading…
Summary: | Polyphosphate (polyP) is a universally conserved molecule that plays critical roles in managing bacterial stress responses, in addition to biofilm formation and virulence. The enzymes that make polyphosphate molecules are called polyphosphate kinases (PPKs). Since these enzymes are not conserved in higher eukaryotes, PPKs make excellent therapeutic targets. In a recent paper in
, Neville and colleagues described gallein, a commercially available G-protein antagonist, as a novel dual-specificity inhibitor against two families of PPK enzymes in Pseudomonas aeruginosa. In this commentary, we discuss the impact of this discovery, outline potential challenges of implementing gallein use in the clinic, and describe how gallein will serve as a fantastic new tool to further fundamental PPK and polyP research in bacteria. |
---|---|
Bibliography: | ObjectType-Article-2 SourceType-Scholarly Journals-1 ObjectType-Feature-3 content type line 23 ObjectType-Commentary-1 For the article discussed, see https://doi.org/10.1128/mBio.00592-21. |
ISSN: | 2150-7511 2150-7511 |
DOI: | 10.1128/mBio.01477-21 |